Risk factor thresholds: Their existence under scrutiny

British Medical Journal

Volumn 324, Issue 7353, 2002, Pages 1570-1576

  Law, M R ^a   Wald, N J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; ENVIRONMENTAL FACTOR; HIGH RISK POPULATION; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

EID: 0037193819     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.324.7353.1570     Document Type: Review

References (48)

1. Prevention of coronary heart disease in clinical practice. Recommendations of the task force of the European society of cardiology
2. Prevention of coronary heart disease in clinical practice: Recommendations of the second joint task force of European and other societies on coronary prevention
3. Lower patients' cholesterol now
4. Joint British recommendations on prevention of coronary heart disease in clinical practice
5. British hypertension society guidelines for hypertension management 1999: Summary
6. Blood pressure, stroke and coronary heart disease. I. Prolonged differences in blood pressure: Prospective observational studies corrected for the regression dilution bias
7. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease
8. Weight, weight change, and coronary heart disease in women. Risk within the 'normal' weight range
9. Diabetes incidence in Pima Indians: Contributions of obesity and parental diabetes
10. Folate levels and neural tube defects
11. Bone density at various sites for prediction of hip fractures
12. Blood pressure, stroke and coronary heart disease. 2. Short-term reductions in blood pressure: Overview of randomised drug trials in their epidemiological context
13. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension
14. Medical Research Council trial of treatment of hypertension in older adults: Principal results
15. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
16. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack
17. Lowering blood pressure to prevent myocardial infarction and stroke: An epidemiological review
18. Post-stroke antihypertensive treatment study
19. Effect of antihypertensive treatment in patients having already suffered from stroke
20. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?
21. Prevention of coronary heart disease with pravastatin in men with hypercholesterolaemia
22. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
23. Baseline serum cholesterol and treatment effect in the Scandinavian Simvastatin Survival Study (4S)
24. Prevention of neural tube defects: Results of the Medical Research Council vitamin study
25. Quantifying the effect of folic acid
26. Serum cholesterol concentration and coronary heart disease in a population with low cholesterol concentrations
27. Differences in proximal femur bone density over two centuries
28. By how much does dietary salt reduction lower blood pressure? 1. Analysis of observational data among populations
29. Antecedents of cardiovascular disease in six Solomon Islands societies
30. Paleolithic nutrition revisited: A twelve-year retrospective on its nature and implications
31. Erythrocyte fatty acids, plasma lipids, and cardiovascular disease in rural China
32. An ecological study of serum cholesterol and ischaemic heart disease between 1950 and 1990
33. Paleolithic Nutrition. A consideration of its nature and current implications
34. The underlying risk of death after myocardial infarction in the absence of treatment
35. Hypertension management and stroke recurrence in a community (Rochester, Minnesota, 1950-1979)
36. When can a risk factor be used as a worthwhile screening test?
37. Apolipoproteins and ischaemic heart disease: Implications for screening
38. Strategies for prevention of osteoporosis and hip fracture
39. Blood pressure, systolic and diastolic, and cardiovascular risks
40. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded?
41. Strategy prevention: Lessons from cardiovascular disease
42. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
43. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
44. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels
45. Familial hypobetalipoproteinemia
46. Longevity syndromes: Familial hypobeta and familial hyperalpha lipoproteinemia